1. 1868 Clinical characteristics, treatment patterns, and outcomes for patients with HER2-positive metastatic breast cancer (MBC) treated with pertuzumab (P) in the first-line in a real-world setting. (September 2015) Authors: Robert, N.; Goertz, H.P.; Asmar, L.; Tseng, W.Y.; Jiao, X.; Portera, C.; Yoo, B.; Patt, D.; Antao, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3327 Survival outcomes in patients (pts) with advanced (adv) melanoma (MEL) with brain metastases treated with 1st-line (1L) ipilimumab (IPI). (September 2015) Authors: Patt, D.; Rao, S.; Espirito, J.; Wilson, T.; Fox, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S673 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗